Trials / Withdrawn
WithdrawnNCT05247749
CONVIVO System to Discriminate Healthy Tissues vs Tumor Tissues During Brain Tumor Resection
Clinical Investigation to Evaluate the CONVIVO System for Discrimination of Normal Tissues From Abnormal Tissues During Brain Tumor Resection
- Status
- Withdrawn
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- Stanford University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of the study is to do a direct comparison of the CONVIVO system (camera imaging device) with our normal Stanford pathology process. CONVIVO system is being tested to see if the device creates the images very quickly by touching a special camera to the surgical wound.
Detailed description
Primary Objective: The primary objective of this study is to determine the feasibility of using the CONVIVO imaging system to identify tumor type. Secondary Objective: The secondary objectives are to determine the average time needed for tissue visualization with the CONVIVO system as compared to standard cryosectioning, and to describe the ability of the CONVIVO imaging -To describe the ability of the CONVIVO imaging system to generate readable images.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | CONVIVO Confocal Endomicroscopy System | Confocal Laser Endomicroscopy (CEM) system intended for viewing intra-operative blood flow in the cerebral vascular area. Manufacturer - Zeiss |
Timeline
- Start date
- 2021-05-01
- Primary completion
- 2022-05-01
- Completion
- 2022-05-01
- First posted
- 2022-02-21
- Last updated
- 2022-02-21
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT05247749. Inclusion in this directory is not an endorsement.